Location: Home
  • search
  • go
  • Relate News
  • 2/11/2014NHFPC Announces Key Tasks for Health and Family Planning in 2014
  • 2/11/2014CR Double Crane to Market Sagent's Orphan Drug in China
  • 2/10/2014Upcoming Event: Pharma China Annual Forum 2014 on April 25 in Shanghai
  • 2/10/2014State Council Orders Initiation of Major Medical Insurance Experiment ...
  • 2/10/2014NHFPC Holds Annual Health Conference Highlighting Reform Path in 2014
  • 2/10/2014Third Clinical Trial Application for H7N9 Vaccine Filed in China
  • 2/10/2014Rohto Pharma Pulls Plug on Its Chinese Cosmetic Business
  • 2/7/2014WHO: China Hit Hardest by Global Surge of Cancers
  • 2/7/2014China's R&D Spending Projected to Surpass EU in 2019 and the US in...
  • 2/7/2014Luye Pharma Plans US$750M IPO in Hong Kong
  • 2/7/2014Chinese Healthcare VC/PE Financing Fell Sharply in 2013
  • 2/7/2014Most Chinese Public Pharma Companies Expect Positive Performance in 20...
  • 2/7/2014Kangmei Signs Pharmacy Contract Management Deals with Nine Medical Ins...
  • 2/6/2014Upcoming Event: Microbiology and Infectious Disease Asia Congress
  • 2/6/2014Why Did One Of The World's Largest Generic Drug Makers Exit China? (Ex...
  • 2/5/2014China Sales of GSK Plunged 18% in 2013 as Global Earnings Rose 20%
  • 2/4/2014Recent Executive Moves
  • 2/4/2014Suven Granted Additional Patents in China for Its CNS Drug Candidates
  • 2/4/2014Sagent Establishes R&D Center in Chengdu
  • 1/30/2014UCB to Develop and Market Biogen Idec's MS and Hemophilia Therapies in...
  • 1/30/2014Chinese Wage Increase Accelerated in 2013
  • 1/29/2014Sinovac Files Clinical Trial Application for H7N9 Vaccine with CFDA
  • 1/29/2014Alibaba to Fund B2C Drug Information Platform
  • 1/29/2014NIFDC Solicits Public Comments on Draft Bioequivalence Guidelines
  • 1/29/2014Shanghai to Experiment Volume-linked Tender Drug Purchase
  • 1/28/2014Takeda Shanghai Initiates Global Phase 3 Trial of Ixazomib
  • 1/28/2014CFDA Announces Appointment of Numerous Senior Officials
  • 1/28/2014Recent Executive Moves
  • 1/28/2014MOFCOM Approves Alliance Boots's Deal to Acquire 12% Stake of Nanjing ...
  • 1/27/2014AstraZeneca, SIBS Enter Partnership for CVD Research
  • Page:481/774 Total number of articles:23193: [First][<<] [479] [480] [481] [482] [483] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group